Human Respiratory Syncytial Virus

Human Respiratory Syncytial Virus: An Introduction.- RSV Growth and Quantification by Microtitration and qRT-PCR Assays.- Quantificationof RSV Infectious Particles by Plaque Assay and Immunostaining Assay.- Detection of RSV Antibodies in Human Plasma by Enzyme Immunoassays.- Secretory Expression and Purification of Respiratory Syncytial Virus G and FProteins in Human Cells.- Development of Human MonoclonalAntibodiesagainst Respiratory Syncytial Virus Using a High Efficiency HumanHybridoma Technique.- Respiratory Syncytial Virus (RSV): Neutralizing Antibody, a Correlate of ImmuneProtection.- Host Factors Modulating RSV Infection; Use of Small Interfering RNAs to ProbeFunctional Importance.- In Vitro Modelling of RSV Infection and Cytopathogenesis inWell-Differentiated Human Primary Airway Epithelial Cells (WD-PAECs).- Reverse Genetics of Respiratory Syncytial Virus.- Use of Minigenome Systems to Study RSVTranscription.- Screening for Host Factors DirectlyInteracting with RSV Protein: Microfluidics.- A Proteomic-Based Workflow Using Purified Respiratory Syncytial Virus Particlesto Identify Cellular Factors as Drug Targets.- MicroRNA Profiling from RSV Infected Biofluids, Whole Blood, and Tissue Samples.- Mouseand Cotton Rat Models of Human Respiratory Syncytial Virus.- In Vivo Assessment of Airway Function in the Mouse Model.- Evaluation of the Adaptive Immune Response to Respiratory Syncytial Virus.